WELCOME to Neurodyn
Neurodyn Inc. (Neurodyn) is a Canadian biotechnology company focused on the discovery of products for early detection and treatment of neurological diseases.From its own discovery program, the company is developing a novel therapeutic, ND-602, which has demonstrated in vivo pre-clinical efficacy in Amyotrophic Lateral Sclerosis (Lou Gehrig's disease), Parkinson's disease, Alzheimer's disease and Spinal Muscular Atrophy (SMA).
In collaboration with the Shanghai Innovative Research Centre for Traditional Chinese Medicine (SIRC) Neurodyn is developing enhanced natural products for neurological diseases. Current work is focused on a ginseng product which has demonstrated in vivo pre-clinical efficacy in an acute as well as proprietary chronic model of Parkinson's disease.
Neurodyn also offers specialty neurological Contract Research Services in ALS, Parkinson's disease, Alzheimer's disease, epilepsy, schizophrenia, stroke and cognitive function testing through its wholly owned subsidiary, CNS CRO.
Overview
Neurologial Disease Development
More information coming soon
ND-602
ND-602 is a patent pending therapeutic that provides unprecedented protection for neurons from damage that can lead to dysfunction and ultimately neuronal death. That is why we believe ND-602 has the potential to become a first-in-class more